Dhanuka Agritech (507717) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
9 Jul, 2026Executive summary
Achieved 6% year-over-year revenue growth in Q2 FY25, reaching INR 654.28 crore, with EBITDA up 13% and PAT up 15.5%.
Board approved unaudited standalone and consolidated financial results for Q2 and H1 FY25, with strong revenue and profit growth year-over-year.
Strong performance driven by new product launches, robust demand for specialty products, and ongoing innovation with expanded R&D and global partnerships.
Aggressive market cleanup and inventory management ensured reported sales reflect true market demand.
Appointment of Mr. Himanshu Singhal as Chief Internal Auditor effective 6th November 2024.
Financial highlights
Revenue from operations: INR 654.28 crore (Q2 FY25) vs INR 617.92 crore (Q2 FY24), up 6%.
EBITDA: INR 159.58 crore, up 13% year-over-year; PAT: INR 117.52 crore, up 15.5% year-over-year.
Gross profit margin improved to 42.18% from 40.29% year-over-year; EBITDA margin rose to 24.39% from 22.91%.
Basic EPS rose 15.7% year-over-year to ₹25.83; H1 FY25 EPS: ₹36.56, up from ₹29.56 in H1 FY24.
Sales returns exceeded INR 100 crore in Q2, up over 40% year-over-year, mainly due to weather-related factors.
Outlook and guidance
Revenue growth guidance revised to 16% for FY25, with 100 bps EBITDA margin improvement expected.
Expect gross margin to improve by at least 100 basis points for the full year.
Inventory expected to normalize by year-end.
Results note that demand depends on monsoon, pest infestation, and crop patterns, leading to potential period-to-period variations.
Latest events from Dhanuka Agritech
- Q1 FY25 saw revenue up 33.74%, profit up 48.45%, and a ₹100 crore share buyback approved.507717
Q1 24/259 Jul 2026 - Q3 FY25 saw strong growth, margin gains, global expansion, and major buyback activity.507717
Q3 24/258 Jul 2026 - Record revenue, global expansion, and share buyback with double-digit growth guided for FY 2026.507717
Q4 24/258 Jul 2026 - Acquisition of two Bayer fungicides expands global reach, revenue, and cost efficiency.507717
M&A Announcement19 Jun 2026 - Q4 saw 9.35% revenue growth, record margins, and a ₹70 crore buyback with global expansion plans.507717
Q4 25/2622 May 2026 - Revenue and profit declined in Q3, but new launches and Dahej ramp-up support future growth.507717
Q3 25/265 Feb 2026 - Q2 FY26 revenue and profit fell YoY on weather and regulatory headwinds; outlook is flat.507717
Q2 25/2614 Dec 2025 - Q1 FY26 revenue up 7% YoY, with improved margins and strong product launches despite headwinds.507717
Q1 25/2616 Nov 2025